Preferred Label : repaglinide;

MeSH note : structure given in first source; RN given refers to repaglinide, the ( )-isomer; AG-EE 623 ZW is the ((S)-( ))-isomer;

CISMeF synonym : AG-EE 623 ZW; NovoNorm; prandin; glaxo wellcome brand of replaginide; novo nordisk brand 2 of repaglinide; novo nordisk brand of repaglinide;

MeSH synonym : repa-glinide; ( )-repaglinide; ( )-2-ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid; (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid;

MeSH hyponym : GlucoNorm; 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid; AG-EE-623ZW; AGEE-623ZW; AG-EE-623-ZW; AG-EE 388 ZW; AG-EE 388; AG-EE-624ZW; repaglinide impurity E; AG-EE 624ZW; 2-ethoxy-4-(2-(((1R)-3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; repaglinide related compound E;

MeSH CAS label : (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid;

MeSH Related Number : repaglinide, ( -)-isomer; 135969-54-9 (( -)-isomer); 135062-02-1; 85M30X62FM;

Registry Number MeSH : 135062-02-1;

Related CAS MeSH : 135969-54-9 (repaglinide, ( -)-isomer);

related registry number list (CISMeF) : 135969-54-9 (( -)-isomer);

Is substance : O;

UNII : 668Z8C33LU;

InChIKey : FAEKWTJYAYMJKF-QHCPKHFHSA-N;

Details


Main resources

You can consult :


https://pharmacomedicale.org/medicaments/par-specialites/item/glinides
2018
false
true
false
France
hypoglycemic agents
repaglinide
diabetes mellitus, type 2
drug information
carbamates
piperidines

---
http://www.has-sante.fr/portail/jcms/c_2630025/fr/repaglinide-arrow-lab
2016
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
repaglinide
carbamates
piperidines

---
http://www.has-sante.fr/portail/jcms/c_2022072/fr/novonorm
http://www.has-sante.fr/portail/jcms/c_969970/novonorm
2015
false
France
French
repaglinide
hypoglycemic agents
administration, oral
repaglinide
insurance, health, reimbursement
diabetes mellitus, type 2
carbamates
piperidines
evaluation of the transparency committee

---
Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/54454a-fra.php
2015
false
false
false
Canada
French
English
drug interactions
repaglinide
repaglinide
clopidogrel
diabetes mellitus, type 2
hypoglycemic agents
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
hypoglycemia
pharmacovigilance note
Cytochrome P-450 CYP2C8 Inhibitors
carbamates
piperidines
Contraindications, Drug
Clopidogrel

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64781540
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67184059
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63601861
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62154877
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66773421
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68124474
2012
France
package leaflet
summary of product characteristics
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62373180
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66142025
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65129402
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60154017
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69259329
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66700754
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65809373
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66951863
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62402205
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63152224
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63303758
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62031077
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63763055
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61650361
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68905544
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68139992
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63919255
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60019069
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61771085
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66319269
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65131823
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60995027
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68536392
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63182089
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63447025
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68841180
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60209531
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62981040
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62724811
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61584712
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68196274
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65365566
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62589274
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64778900
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62006750
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65677893
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
https://www.ema.europa.eu/medicines/human/EPAR/Prandin
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
carbamates
diabetes mellitus, type 2
piperidines
drug interactions
carbamates
piperidines
hypoglycemic agents
treatment outcome
drug evaluation
drug labeling
drug approval
tablets
administration, oral
drug therapy, combination
pregnancy
breast feeding
repaglinide
repaglinide
repaglinide
carbamates
piperidines
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Novonorm
2012
United Kingdom
English
French
syndication feed
carbamates
piperidines
hypoglycemic agents
carbamates
piperidines
hypoglycemic agents
drug interactions
treatment outcome
drug evaluation
pregnancy
drug approval
drug labeling
tablets
administration, oral
drug therapy, combination
breast feeding
diabetes mellitus, type 2
repaglinide
repaglinide
repaglinide
carbamates
piperidines
summary of product characteristics
drug evaluation
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Repaglinide-Krka
2012
United Kingdom
French
English
syndication feed
carbamates
hypoglycemic agents
piperidines
repaglinide
repaglinide
carbamates
piperidines
hypoglycemic agents
repaglinide
drug approval
drug labeling
treatment outcome
diabetes mellitus, type 2
tablets
administration, oral
drugs, generic
drug interactions
pregnancy
breast feeding
carbamates
piperidines
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Enyglid
2012
United Kingdom
French
English
syndication feed
repaglinide
carbamates
carbamates
piperidines
piperidines
repaglinide
repaglinide
drug approval
drug labeling
treatment outcome
tablets
administration, oral
drugs, generic
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 2
drug therapy, combination
adult
drug interactions
pregnancy
carbamates
piperidines
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Repaglinide-Teva
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
carbamates
piperidines
repaglinide
repaglinide
hypoglycemic agents
carbamates
piperidines
diabetes mellitus, type 2
drug therapy, combination
drug approval
drug labeling
treatment outcome
tablets
administration, oral
drugs, generic
adult
aged
drug interactions
pregnancy
breast feeding
carbamates
piperidines
drug evaluation
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65594376
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61380446
2012
France
summary of product characteristics
package leaflet
tablets
repaglinide

---
https://www.ema.europa.eu/medicines/human/EPAR/Repaglinide-Accord
2012
United Kingdom
English
French
syndication feed
repaglinide
drug approval
treatment outcome
repaglinide
drugs, generic
administration, oral
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 2
repaglinide
drug interactions
pregnancy
breast feeding
insulin-secreting cells
adult
carbamates
carbamates
piperidines
piperidines
summary of product characteristics
package leaflet
drug evaluation

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61569137
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64300334
2012
France
summary of product characteristics
package leaflet
repaglinide
tablets

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.